Slide 1: Quarterly Performance Update Q2 FY-17
Quarterly Performance Update Q2 FY-17 Kaya Limited 1
Slide 2: Disclaimer
Disclaimer This investor presentation has been prepared by Kaya Limited (“Kaya”) and does not constitute a prospectus or placement memorandum or an offer to acquire any securities. This presentation or any other documentation or information (or any part thereof) delivered or supplied should not be d
Slide 3: Kaya Group: Key Highlights – Q2 FY 17
Kaya Group : Key Highlights – Q2 FY 17 • Net Revenue (NR) for Q2 FY 17 at INR 1022 Mn has grown by 16%. Same store growth (SSG: 13%) • SSG @ constant currency is 11% • EBIDTA of INR 48 Mn (5% of NR) compared to EBIDTA of INR 32 Mn (4% of NR) in Q2 FY 16 , growth of 48% , majorly due to better perfor
Slide 4: Financial Summary – Q2 FY17
Financial Summary – Q2 FY17 Net Revenue (INR Mn) EBIDTA (INR Mn) Q2 FY 17 1,022 Q2 FY 17 48 Q2 FY 16 885 16% Q2 FY 16 32 48% 0 300 600 900 1200 0 10 20 30 40 50 60 EBIDTA Margin % PAT % Q2 FY 17 5% Q2 FY 17 3% Q2 FY 16 4% Q2 FY 16 3% 0% 1% 2% 3% 4% 5% 6% 0% 1% 2% 3% 4% 4
Slide 5: Awards & Recognition
Awards & Recognition India – •“Healthcare Excellence Awards- CIMS” – Award for Best Cosmetic Solution Provider Co. •“Asia Awards for Excellence in Branding & Marketing- CMO” - Award for Best Loyalty Program & Brand Excellence in Beauty, Wellness Sector •“Digital campaign of the year” – Award for Bes
Slide 6: Kaya India Region
Kaya India Region kaya
Slide 7: Kaya India: Key Highlights
Kaya India : Key Highlights • Net Revenue for Q2 FY 17 at INR 492 Mn has grown by 8% (SSG:5%) • Ecommerce NR at Rs 8 Mn grew by 113% over Q2 LY, contributing 9% of Product revenue. • EBIDTA at INR (19) Mn ( - 4% of NR) compared to EBIDTA of INR (29) Mn ( - 6% to NR) in Q2 LY. , • EBDITA loss reduced
Slide 8: Our Presence in India
Our Presence in India 103 Clinics 128 Kaya Skin Bars 27 Cities 16 Indian states Opened in Q2 FY 17 1 SIS –KSB 1 Clinic & 1 KSB CoCo / 5 SIS closed in Q2FY17 8 The picture above just gives an idea of location and don’t represent exact scale
Slide 9: Operational Indicators – India (clinics only)
Operational Indicators – India (clinics only) 68000 11000 64,319 9,973 10,006 64000 10000 59,664 9000 60000 56000 8000 8% 0% 52000 2% 7000 48000 6000 44000 5000 40000 4000 Q2 FY 16 Q2 FY 17 Q2 FY 16 Q2 FY 17 Customer count Ticket Size (Rs) • Customer count grew by 8% over LY. (SSG: 3.5%) • Ticket si
Slide 10: Category Mix % - India (clinics only)
Category Mix % - India (clinics only) 7% 80% 73% 72% 70% 60% 50% 40% 28% 30% - 1% 20% 12% 14% 14% 13% 10% 0% Cure Care Products Q2 FY 16 Q2 FY 17 • Cure category has grown by 7% (SSG: 2%) in Q2 FY 17 • Care Category ( Facials ) grew by 28% (SSG: 24%) in Q2 FY 17 • In Clinic Product sales de-grew by
Slide 11: Kaya Middle East Region
Kaya Middle East Region 11
Slide 12: Kaya Middle East: Key Highlights
Kaya Middle East : Key Highlights • Net Revenue at INR 530 Mn for Q2 FY 17 has grown by 24%. Same store growth (SSG : 20%). • SSG @ constant currency for Q2 FY 17 is 16% • Ticket size grew by 5% over Q2 FY 16 • EBIDTA of INR 67 Mn (13% of NR) compared to EBIDTA of INR 61 Mn (14% of NR) in Q2 FY 16 •
Slide 13: Our Presence in GCC
Our Presence in GCC… 21 Clinics 4 Countries 10 Cities 13 The picture above iust gives an idea of location and don’t represent exact scale
Slide 14: Operational Indicators – Middle East
Operational Indicators – Middle East 20000 440 420 17637 420 408 18000 16513 400 16000 380 7% 3% 14000 360 340 12000 320 10000 300 Q2 FY 16 Q2 FY 17 Q2 FY 16 Q2 FY 17 Customer count Ticket Size (USD) • Customer count has grown by 7% (SSG: 1%) over Q2 LY. • Growth in Hair Free category is driving the
Slide 15: Category Mix % - KME Region
Category Mix % - KME Region 13% 90% 80% 75% 77% 70% 60% 50% 40% 7% - 4% 30% 20% 14% 13% 11% 9% 10% 0% Cure Care Products Q2 FY 16 Q2 FY 17 • Cure category has grown by 13% (SSG: 8%) in Q2 FY 17. • Hair free technology scale up in all clinics helped to drive growth. • Care category grew by 7% (SSG: -
Slide 16: Financials – Q2 FY 17
Financials – Q2 FY 17 16
Slide 17: Financial Highlights: Kaya Group
Financial Highlights : Kaya Group Particulars (INR Mn) Q2 FY 16 Q2 FY 17 Collection SSG 8% Collection 1062 1171 6% @ constant currency 10% Net Revenue SSG 13% Net Revenue 885 1022 16% 11% @ constant currency EBIDTA 32 48 EBIDTA at 5% against 4% LY Operating Margin -7 1 Operating margin at flat Again
Slide 18: Financial Highlights: India
Financial Highlights : India Particulars (INR Mn) Q2 FY 16 Q2 FY 17 Collection SSG (Clinics) 7% Collection 625 676 12% Net Revenue SSG (Clinics) 5% Net Revenue 456 492 13% EBIDTA -29 -19 EBIDTA margin at - 4 % against - 6% of Q2 LY Operating Margin -51 -46 Operating margin at - 9% against - 11 % in
Slide 19: Financial Highlights: Middle East
Financial Highlights : Middle East Particulars (INR Mn) Q2 FY 16 Q2 FY 17 Collection SSG 10% Collection 437 496 6% @ constant currency 13% Net Revenue SSG 20% Net Revenue 428 530 24% 16% @ constant currency EBIDTA margin at 13% EBIDTA 61 67 against 14% Q2 LY impacted by new clinic in Kuwait Operatin
Slide 20: Investor relations contact
In case of any clarifications please contact on investorrelations@kayaindia.net 20
Slide 21: Thank you
Thank you 21